APA (7th ed.) Citation

Nag, K., Sarker, E. H., Kumar, S., Chakraborty, S., Khan, M. R., Chowdhury, M. R., . . . Sultana, N. (2023). Satisfying QTPP of Erythropoietin Biosimilar by QbD through DoE-Derived Downstream Process Engineering. Pharmaceutics, 15(8), 2087. https://doi.org/10.3390/pharmaceutics15082087

Chicago Style (17th ed.) Citation

Nag, Kakon, et al. "Satisfying QTPP of Erythropoietin Biosimilar by QbD Through DoE-Derived Downstream Process Engineering." Pharmaceutics 15, no. 8 (2023): 2087. https://doi.org/10.3390/pharmaceutics15082087.

MLA (9th ed.) Citation

Nag, Kakon, et al. "Satisfying QTPP of Erythropoietin Biosimilar by QbD Through DoE-Derived Downstream Process Engineering." Pharmaceutics, vol. 15, no. 8, 2023, p. 2087, https://doi.org/10.3390/pharmaceutics15082087.